In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes

References

• Ahn KS, Jung KY, Kim JH, Oh SR, Lee HK. (2001). Inhibitory activity of lignan components from the flower buds of Magnoliae fargesii on the expression of cell adhesion molecules. Biol Pharm Bull 24:1085–1087.
   PubMedGoogle Scholar
• Baek JA, Lee YD, Lee CB, Go HK, Kim JP, Seo JJ, Rhee YK, Kim AM, Na DJ. (2009). Extracts of Magnoliae flos inhibit inducible nitric oxide synthase via ERK in human respiratory epithelial cells. Nitric Oxide 20:122–128.
   PubMedGoogle Scholar
• Baldwin SJ, Clarke SE, Chenery RJ. (1999). Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. Br J Clin Pharmacol 48:424–432.
   PubMed Web of Science ®Google Scholar
• Bidstrup TB, Bjørnsdottir I, Sidelmann UG, Thomsen MS, Hansen KT. (2003). CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. Br J Clin Pharmacol 56:305–314.
   PubMed Web of Science ®Google Scholar
• Chae SH, Kim PS, Cho JY, Park JS, Lee JH, Yoo ES, Baik KU, Lee JS, Park MH. (1998). Isolation and identification of inhibitory compounds on TNF-alpha production from Magnolia fargesii. Arch Pharm Res 21:67–69.
   PubMed Web of Science ®Google Scholar
• Cresteil T, Monsarrat B, Dubois J, Sonnier M, Alvinerie P, Gueritte F. (2002). Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship. Drug Metab Dispos 30:438–445.
   PubMed Web of Science ®Google Scholar
• Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT. (2010). Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast. Clin Pharmacol Ther 88:223–230.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lim HJ, Lee da Y, Kim JS, Kim do H, Lee HJ, Kim HD, Jeon R, Ryu JH. (2009). In vitro anti-inflammatory activity of lignans isolated from Magnolia fargesii. Bioorg Med Chem Lett 19:937–940.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim JY, Lee HJ, Lim HJ, Lee da Y, Kim do H, Ryu JH. (2010a). Suppression of inducible nitric oxide synthase expression by furfuran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells. Phytother Res 24:748–753.
   PubMedGoogle Scholar
• Kim NJ, Song WY, Yoo SD, Oh SR, Lee HK, Lee HS. (2010b). Pharmacokinetics of magnolin in rats. Arch Pharm Res 33:933–938.
   PubMedGoogle Scholar
• Lai XS, Yang LP, Li XT, Liu JP, Zhou ZW, Zhou SF. (2009). Human CYP2C8: structure, substrate specificity, inhibitor selectivity, inducers and polymorphisms. Curr Drug Metab 10:1009–1047.
   PubMed Web of Science ®Google Scholar
• Lee HK, Jung KY, Ahn KS, Oh SR, Lee IS, Park SH, Kim JH, Jang HW, Hong ND (inventors). Korea Institute of Science & Technology (assignee). (2002). New lignans isolated from Magnolia flos with leukotriene synthesis inhibitory activity. Korea Patent, 10-0321313-0000.
   Google Scholar
• Li XQ, Björkman A, Andersson TB, Ridderström M, Masimirembwa CM. (2002). Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. J Pharmacol Exp Ther 300:399–407.
   PubMed Web of Science ®Google Scholar
• Lim H, Son KH, Bae KH, Hung TM, Kim YS, Kim HP. (2009). 5-lipoxygenase-inhibitory constituents from Schizandra fructus and Magnolia flos. Phytother Res 23:1489–1492.
   PubMedGoogle Scholar
• Miyazawa M, Kasahara H, Kameoka H. (1993a). Biotransformation of (+)-magnolin and (+)-yangabin in rat. Phytochemistry, 32, 1421–1424.
   Web of Science ®Google Scholar
• Miyazawa M, Kasahara H, Kameoka H. (1993b). Biotransformation of lignans: a specific microbial oxidation of (+)-eudesmin and (+)-magnolin by Aspergillus Niger. Phytochemistry, 34, 1501–1507.
   Web of Science ®Google Scholar
• Miyazawa M, Kasahara H, Kameoka H. (1995). Biotransformation of lignans: metabolism of (+)-eudesmin and (+)-magnolin in Spodoptera Litura. Phytochemistry, 39, 1027–1030.
   Web of Science ®Google Scholar
• Park JY, Kim KA, Kang MH, Kim SL, Shin JG. (2004). Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects. Clin Pharmacol Ther 75:157–162.
   PubMed Web of Science ®Google Scholar
• Rodrigues AD. (1999). Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem Pharmacol 57:465–480.
   PubMed Web of Science ®Google Scholar
• Shen Y, Pang EC, Xue CC, Zhao ZZ, Lin JG, Li CG. (2008a). Inhibitions of mast cell-derived histamine release by different Flos Magnoliae species in rat peritoneal mast cells. Phytomedicine 15:808–814.
   PubMedGoogle Scholar
• Shen Y, Li CG, Zhou SF, Pang EC, Story DF, Xue CC. (2008b). Chemistry and bioactivity of Flos Magnoliae, a Chinese herb for rhinitis and sinusitis. Curr Med Chem 15:1616–1627.
   PubMedGoogle Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423.
   PubMed Web of Science ®Google Scholar
• Vormfelde SV, Brockmöller J, Bauer S, Herchenhein P, Kuon J, Meineke I, Roots I, Kirchheiner J. (2009). Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteers. Clin Pharmacol Ther 86:54–61.
   PubMed Web of Science ®Google Scholar
• Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ. (2002). Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes. Drug Metab Dispos 30:1352–1356.
   PubMed Web of Science ®Google Scholar